The United States Cardiac Implant Closure Device Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Cardiac Implant Closure Device Market By Application
- Atrial Septal Defect (ASD)
- Ventricular Septal Defect (VSD)
- Patent Foramen Ovale (PFO)
- Left Atrial Appendage Closure (LAAC)
- Others
The United States cardiac implant closure device market is segmented by application into several key segments. Atrial Septal Defect (ASD) closures account for a significant portion of the market, driven by increasing prevalence of ASD and advancements in minimally invasive closure techniques. Ventricular Septal Defect (VSD) closures also hold a notable share, supported by the rising incidence of congenital heart defects and the effectiveness of closure devices in managing these conditions.
Patent Foramen Ovale (PFO) closures are witnessing steady growth owing to the association of PFO with cryptogenic strokes and the adoption of closure devices for reducing the risk of recurrent strokes. Left Atrial Appendage Closure (LAAC) devices are gaining traction due to their role in reducing the risk of stroke in atrial fibrillation patients who are ineligible for long-term anticoagulation therapy. Other applications, including closure devices for complex congenital heart defects and post-procedural leaks, represent a niche yet promising segment with evolving technological innovations and expanding clinical indications.